Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
PHASE IIIb, MULTICENTRE, OPEN-LABEL, SINGLE-ARM, STUDY TO ASSESS THE EFFICACY AND SAFETY OF LANREOTIDE AUTOGEL 120 mg ADMINISTERED EVERY 28 DAYS AS PRIMARY MEDICAL TREATMENT IN ACROMEGALIC PATIENTS WITH MACROADENOMA https://kusajili.com:443/Trial/doW_v_3Q20KEOXadhUPiig%24phase-iiib-multicentre-open-label-single-arm-study-to-assess-the-efficacy-and-safety-of-lanreotide-autogel-120-mg-administered-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message